Related Experiment Video
Updated: Mar 13, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Triple Antithrombotic Therapy and Outcomes in Post-PCI Patients Undergoing Non-cardiac Surgery
Javier A Valle1,2, Laura Graham3, Aerin DeRussy3
1VA Eastern Colorado Health Care System, University of Colorado School of Medicine, Denver, CO, USA. Javier.valle@ucdenver.edu.
Insights
Patients on triple therapy after percutaneous coronary intervention (PCI) face higher risks of major adverse cardiovascular and cerebrovascular events (MACCE) and bleeding during non-cardiac surgery compared to those on dual antiplatelet therapy (DAPT). This highlights a high-risk surgical group needing closer monitoring.
Area of Science:
- Cardiology
- Vascular Surgery
- Pharmacology
Background:
- Triple therapy (anticoagulants plus dual antiplatelet therapy) is used post-percutaneous coronary intervention (PCI) to prevent ischemic events.
- This therapy increases bleeding risk, which may be amplified in the perioperative period for patients undergoing surgery.
- Outcomes for post-PCI patients on triple therapy undergoing non-cardiac surgery are not well-established.
Purpose of the Study:
- To evaluate the perioperative risks associated with triple therapy versus dual antiplatelet therapy (DAPT) in patients undergoing non-cardiac surgery after PCI.
- To compare rates of major adverse cardiovascular and cerebrovascular events (MACCE) and bleeding between these two therapeutic groups.
Main Methods:
- Retrospective analysis of Veterans Affairs hospital data (2004-2012).
- Identified patients undergoing non-cardiac surgery within two years of PCI.
- Compared perioperative MACCE and bleeding events between patients on triple therapy and DAPT, adjusting for covariates.
Main Results:
- Of 7811 surgeries, 5.0% were in patients on triple therapy.
- Triple therapy patients had higher rates of MACCE (11.3% vs. 4.9%) and bleeding (27.4% vs. 13.2%) compared to DAPT patients.
- Adjusted analysis showed triple therapy was associated with increased MACCE (OR 1.65) and bleeding (OR 1.52).
Conclusions:
- Post-PCI patients undergoing non-cardiac surgery on triple therapy represent a high-risk population.
- Surgery in this group is linked to significantly higher rates of MACCE and bleeding, irrespective of other factors.
- Increased surveillance for adverse perioperative events is warranted for these patients.
Background:
Triple therapy, or the use of anticoagulants with dual antiplatelet therapy (DAPT), is often used to protect against ischemic events in post-percutaneous coronary intervention (PCI) patients with indications for anticoagulation, but is associated with increased bleeding. As both ischemic and bleeding risks increase in the perioperative period, the impact of triple therapy may be especially pronounced in patients undergoing surgery. Outcomes in this population are currently unknown.
Methods:
We identified patients undergoing non-cardiac surgeries within 2 years of PCI in Veterans Affairs hospitals from 2004 to 2012. We compared perioperative major adverse cardiovascular and cerebrovascular events (MACCE: mortality, myocardial infarction, stroke, revascularization) and bleeding events (in-hospital bleeding, transfusion) between surgeries in patients prescribed triple therapy and DAPT, adjusting for clinical, demographic, and operative characteristics.
Results:
Among 7811 surgeries, 391 (5.0 %) occurred in patients receiving triple therapy. 44 (11.3 %) MACCE and 107 (27.4 %) bleeding events occurred with surgeries in triple therapy patients, compared to 366 (4.9 %) MACCE and 980 (13.2 %) bleeding events in DAPT patients. After adjustment, surgery in triple therapy patients was associated with higher rates of MACCE [odds ratio (OR) 1.65, 95 % confidence interval (CI) 1.16-2.34] or bleeding (OR 1.52, 95 % CI 1.17-1.99) as compared to surgery in DAPT patients.
Conclusions:
One in twenty post-PCI patients undergoing non-cardiac surgery were on triple therapy. Surgery in these patients was associated with higher MACCE and bleeding events compared to surgery in patients on DAPT, independent of clinical and operative characteristics. These findings identify a high-risk population for surgery, which may warrant increased surveillance for adverse perioperative events.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management